Skip to main content
Top
Published in: Pituitary 1/2007

01-03-2007 | Case Report

Fatal inflammatory hypophysitis

Authors: Elizabeth A. McIntyre, Petros Perros

Published in: Pituitary | Issue 1/2007

Login to get access

Abstract

A young female patient presented as an acute medical emergency with hypoglycaemia. Investigations revealed panhypopituitarism and an inflammatory pituitary mass. An antibody screen was negative for anti-neutrophil cytoplasmic antibodies with cytoplasmic distribution (cANCA). Pituitary histology showed lymphocytic infiltration and a few Langerhan’s cells. The pituitary mass rapidly expanded to involve the optic nerves and led to bilateral blindness. Later, the patient developed diarrhoea, a vasculitis rash, scleritis, and proteinuria. In subsequent investigations cANCA became positive. The patient responded to steroids and cyclophosphamide treatment and remained in partial remission for six months before dying of severe sepsis. This is the first description of Wegener’s granulomatosis presenting with acute anterior pituitary failure in the absence of other organ involvement and negative serology.
Literature
1.
go back to reference Sam S, Molitch ME (2005) The pituitary mass: diagnosis and management. Rev Endocr Metab Disord 6:55–62PubMedCrossRef Sam S, Molitch ME (2005) The pituitary mass: diagnosis and management. Rev Endocr Metab Disord 6:55–62PubMedCrossRef
2.
go back to reference Cheung CC, Ezzat S, Smyth HS, Asa SL (2001) The spectrum and significance of primary hypophysitis. J Clin Endocrinol Metab 86:1048–1053PubMedCrossRef Cheung CC, Ezzat S, Smyth HS, Asa SL (2001) The spectrum and significance of primary hypophysitis. J Clin Endocrinol Metab 86:1048–1053PubMedCrossRef
3.
go back to reference Rodriguez-Pereira C, Borras-Moreno JM, Pesudo-Martinez JV, Vera-Roman JM (2005) Cerebral solitary Langerhans cell histiocytosis: report of two cases and review of the literature. Br J Neurosurg 19:192–197PubMed Rodriguez-Pereira C, Borras-Moreno JM, Pesudo-Martinez JV, Vera-Roman JM (2005) Cerebral solitary Langerhans cell histiocytosis: report of two cases and review of the literature. Br J Neurosurg 19:192–197PubMed
4.
go back to reference Caturegli P, Newschaffer C, Olivi A, Pomper MG, Burger PC, Rose NR (2005) Autoimmune hypophysitis. Endocr Rev 26:599–614PubMedCrossRef Caturegli P, Newschaffer C, Olivi A, Pomper MG, Burger PC, Rose NR (2005) Autoimmune hypophysitis. Endocr Rev 26:599–614PubMedCrossRef
6.
go back to reference Sautner D, Saeger W, Lüdecke DK, Jansen V, Puchner MJA (1995) Hypophysitis in surgical and autoptical specimens. Acta Neuropathol (Berl) 90:637–644 Sautner D, Saeger W, Lüdecke DK, Jansen V, Puchner MJA (1995) Hypophysitis in surgical and autoptical specimens. Acta Neuropathol (Berl) 90:637–644
7.
go back to reference Lury KM (2005) Inflammatory and infectious processes involving the pituitary gland. Top Magn Reson Imaging 16:301–306PubMedCrossRef Lury KM (2005) Inflammatory and infectious processes involving the pituitary gland. Top Magn Reson Imaging 16:301–306PubMedCrossRef
8.
go back to reference Burt MG, Morey AL, Turner JJ, Pell M, Sheehy JP, Ho KK (2003) Xanthomatous pituitary lesions: a report of two cases and review of the literature. Pituitary 6:161–168PubMedCrossRef Burt MG, Morey AL, Turner JJ, Pell M, Sheehy JP, Ho KK (2003) Xanthomatous pituitary lesions: a report of two cases and review of the literature. Pituitary 6:161–168PubMedCrossRef
9.
go back to reference Roncaroli F, Bacci A, Frank G, Calbucci F (1998) Granulomatous hypophysitis caused by a ruptured intrasellar Rathke’s cleft cyst: report of a case and review of the literature. Neurosurgery 43:146–149PubMedCrossRef Roncaroli F, Bacci A, Frank G, Calbucci F (1998) Granulomatous hypophysitis caused by a ruptured intrasellar Rathke’s cleft cyst: report of a case and review of the literature. Neurosurgery 43:146–149PubMedCrossRef
10.
go back to reference Toth M, Szabo P, Racz K, Szende B, Balogh I, Czirjak S, Slowik F, Glaz E (1996) Granulomatous hypophysitis associated with Takayasu’s disease. Clin Endocrinol 45:499–503CrossRef Toth M, Szabo P, Racz K, Szende B, Balogh I, Czirjak S, Slowik F, Glaz E (1996) Granulomatous hypophysitis associated with Takayasu’s disease. Clin Endocrinol 45:499–503CrossRef
11.
go back to reference de Bruin WI, van’t Verlaat JW, Graamans K, de Bruin TW (1991) Sellar granulomatous mass in a pregnant woman with active Crohn’s disease. Neth J Med 39:136–141PubMed de Bruin WI, van’t Verlaat JW, Graamans K, de Bruin TW (1991) Sellar granulomatous mass in a pregnant woman with active Crohn’s disease. Neth J Med 39:136–141PubMed
13.
go back to reference Seror R, Mahr A, Ramanoelina J, Pagnoux C, Cohen P, Guillevin L (2006) Central nervous system involvement in Wegener granulomatosis. Medicine (Baltimore) 85:54–65 Seror R, Mahr A, Ramanoelina J, Pagnoux C, Cohen P, Guillevin L (2006) Central nervous system involvement in Wegener granulomatosis. Medicine (Baltimore) 85:54–65
14.
go back to reference Miesen WM, Janssens EN, van Bommel EF (1999) Diabetes insipidus as the presenting symptom of Wegener’s granulomatosis. Nephrol Dialys Transplant 14:426–429CrossRef Miesen WM, Janssens EN, van Bommel EF (1999) Diabetes insipidus as the presenting symptom of Wegener’s granulomatosis. Nephrol Dialys Transplant 14:426–429CrossRef
15.
go back to reference Tappouni R, Burns A (2000) Pituitary involvement in Wegener’s granulomatosis. Nephrol Dialys Transplant 15:2057–2058CrossRef Tappouni R, Burns A (2000) Pituitary involvement in Wegener’s granulomatosis. Nephrol Dialys Transplant 15:2057–2058CrossRef
16.
go back to reference Goyal M, Kucharczyk W, Keystone E (2000) Granulomatous hypophysitis due to Wegener’s granulomatosis. Am J Neuroradiol 21:1466–1469PubMed Goyal M, Kucharczyk W, Keystone E (2000) Granulomatous hypophysitis due to Wegener’s granulomatosis. Am J Neuroradiol 21:1466–1469PubMed
17.
go back to reference Garovic VD, Clarke BL, Chilson TS, Specks U (2001) Diabetes insipidus and anterior pituitary insufficiency as presenting features of Wegener’s granulomatosis. Am J Kidn Dis 37:E5 Garovic VD, Clarke BL, Chilson TS, Specks U (2001) Diabetes insipidus and anterior pituitary insufficiency as presenting features of Wegener’s granulomatosis. Am J Kidn Dis 37:E5
18.
go back to reference Duzgun N, Morris Y, Gullu S, Gursoy A, Ensari A, Kumbasar OO, Duman M (2005) Diabetes insipidus presentation before renal and pulmonary features in a patient with Wegener’s granulomatosis. Rheumatol Internat 26:80–82CrossRef Duzgun N, Morris Y, Gullu S, Gursoy A, Ensari A, Kumbasar OO, Duman M (2005) Diabetes insipidus presentation before renal and pulmonary features in a patient with Wegener’s granulomatosis. Rheumatol Internat 26:80–82CrossRef
19.
go back to reference Batsakis JG, Luna MA (1987) Midfacial necrotizing lesions. Semin Diagn Pathol 4:90–116PubMed Batsakis JG, Luna MA (1987) Midfacial necrotizing lesions. Semin Diagn Pathol 4:90–116PubMed
20.
go back to reference Stone JH (2003) Limited versus severe Wegener’s granulomatosis: baseline data on patients in the Wegener’s granulomatosis etanercept trial. Arthr Rheumat 48:2299–2309CrossRef Stone JH (2003) Limited versus severe Wegener’s granulomatosis: baseline data on patients in the Wegener’s granulomatosis etanercept trial. Arthr Rheumat 48:2299–2309CrossRef
21.
22.
go back to reference Haynes BF, Fauci AS (1978) Diabetes insipidus associated with Wegener’s granulomatosis successfully treated with cyclophosphamide. N Engl J Med 299:764PubMedCrossRef Haynes BF, Fauci AS (1978) Diabetes insipidus associated with Wegener’s granulomatosis successfully treated with cyclophosphamide. N Engl J Med 299:764PubMedCrossRef
23.
go back to reference Murphy JM, Gomez-Anson B, Gillard JH, Antoun NM, Cross J, Elliot JD, Lockwood M (1999) Wegener granulomatosis: MR imaging findings in brain and meninges. Radiology 213:794–799PubMed Murphy JM, Gomez-Anson B, Gillard JH, Antoun NM, Cross J, Elliot JD, Lockwood M (1999) Wegener granulomatosis: MR imaging findings in brain and meninges. Radiology 213:794–799PubMed
24.
go back to reference Kallenberg CGM, Mulder AHL, Tervaert JWC (1992) Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders. Am J Med 93:675–681PubMedCrossRef Kallenberg CGM, Mulder AHL, Tervaert JWC (1992) Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders. Am J Med 93:675–681PubMedCrossRef
25.
go back to reference George J, Levy Y, Kallenberg CGM, Schoenfeld Y (1997) Infections and Wegener’s granulomatosis-a cause and effect relationship? Q J Med 90:367–373 George J, Levy Y, Kallenberg CGM, Schoenfeld Y (1997) Infections and Wegener’s granulomatosis-a cause and effect relationship? Q J Med 90:367–373
26.
go back to reference Katzman GL, Langford CA, Sneller MC, Koby M, Patronas NJ (1999) Pituitary involvement by Wegener’s granulomatosis: a report of two cases. AJNR Am J Neuroradiol 20:519–23PubMed Katzman GL, Langford CA, Sneller MC, Koby M, Patronas NJ (1999) Pituitary involvement by Wegener’s granulomatosis: a report of two cases. AJNR Am J Neuroradiol 20:519–23PubMed
27.
go back to reference Goyal M, Kucharczyk W, Keystone E (2000) Granulomatous hypophysitis due to Wegener’s granulomatosis. AJNR Am J Neuroradiol 21:1466–1499PubMed Goyal M, Kucharczyk W, Keystone E (2000) Granulomatous hypophysitis due to Wegener’s granulomatosis. AJNR Am J Neuroradiol 21:1466–1499PubMed
Metadata
Title
Fatal inflammatory hypophysitis
Authors
Elizabeth A. McIntyre
Petros Perros
Publication date
01-03-2007
Published in
Pituitary / Issue 1/2007
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-007-0016-z

Other articles of this Issue 1/2007

Pituitary 1/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine